ArticleCureus2026
Reversible Rapidly Progressive Dementia Due to Cerebral Amyloid Angiopathy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral amyloid angiopathy (CAA) is a vascular disorder of the brain caused by beta-amyloid deposits in small- and medium-sized vessels. In some patients, the condition triggers an inflammatory response, which can appear in different forms based on the pattern of vessel involvement. These rare but treatable inflammatory variants may present with a syndrome of rapidly progressive dementia, which may pose a diagnostic challenge. Here, we describe a 76-year-old man who experienced two distinct episodes of rapidly progressive cognitive deterioration accompanied by diffuse weakness and seizure activity, separated by a seven-year interval. Despite extensive diagnostic evaluation during the initial presentation, a definitive diagnosis was not established. During the second episode, advanced neuroimaging revealed characteristic asymmetric white matter changes, and subsequent histopathologic examination confirmed cerebral amyloid angiopathy-related inflammation (CAA-ri). This case underscores the diagnostic complexity of CAA-ri and highlights the importance of clinicoradiologic correlation and tissue confirmation in atypical or recurrent presentations of rapidly progressive dementia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.